1. Sodium phenylbutyrate-taurursodiol slowed the functional decline in patients with amyotrophic lateral sclerosis.
2. The mean rate of change for slow vital capacity and plasma phosphorylated axonal neurofilament H subunit were not significantly different between the treatment and control groups.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Amyotrophic lateral sclerosis (ALS) causes...